Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas

Fabio M. Iwamoto, Andreas F. Hottinger, Sasan Karimi, Elyn Riedel, Jocelynn Dantis, Maryam Jahdi, Katherine S. Panageas, Andrew B. Lassman, Lauren E. Abrey, Martin Fleisher, Lisa M. Deangelis, Eric C. Holland, Adília Hormigo

Research output: Contribution to journalArticlepeer-review

69 Scopus citations

Fingerprint

Dive into the research topics of 'Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas'. Together they form a unique fingerprint.

Medicine & Life Sciences